360 related articles for article (PubMed ID: 28140518)
1. Metabonomics by proton nuclear magnetic resonance in human pleural effusions: A route to discriminate between benign and malignant pleural effusions and to target small molecules as potential cancer biomarkers.
Zennaro L; Vanzani P; Nicolè L; Cappellesso R; Fassina A
Cancer Cytopathol; 2017 May; 125(5):341-348. PubMed ID: 28140518
[TBL] [Abstract][Full Text] [Related]
2. Pleural effusion lipoproteins measured by NMR spectroscopy for diagnosis of exudative pleural effusions: a novel tool for pore-size estimation.
Lam CW; Law CY
J Proteome Res; 2014 Sep; 13(9):4104-12. PubMed ID: 25072840
[TBL] [Abstract][Full Text] [Related]
3. Sestrin-2 is significantly increased in malignant pleural effusions due to lung cancer and is potentially secreted by pleural mesothelial cells.
Tsilioni I; Filippidis AS; Kerenidi T; Budanov AV; Zarogiannis SG; Gourgoulianis KI
Clin Biochem; 2016 Jun; 49(9):726-728. PubMed ID: 26874199
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic analysis based on 1H-nuclear magnetic resonance spectroscopy metabolic profiles in tuberculous, malignant and transudative pleural effusion.
Wang C; Peng J; Kuang Y; Zhang J; Dai L
Mol Med Rep; 2017 Aug; 16(2):1147-1156. PubMed ID: 28627685
[TBL] [Abstract][Full Text] [Related]
5. Metabonomic classification and detection of small molecule biomarkers of malignant pleural effusions.
Zhou XM; He CC; Liu YM; Zhao Y; Zhao D; Du Y; Zheng WY; Li JX
Anal Bioanal Chem; 2012 Dec; 404(10):3123-33. PubMed ID: 23052876
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions.
Han CH; Choi JE; Chung JH
Intern Med; 2008; 47(19):1669-74. PubMed ID: 18827414
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin is upregulated in malignant and inflammatory pleural effusions.
Moschos C; Porfiridis I; Psallidas I; Kollintza A; Stathopoulos GT; Papiris SA; Roussos C; Kalomenidis I
Respirology; 2009 Jul; 14(5):716-22. PubMed ID: 19476604
[TBL] [Abstract][Full Text] [Related]
8. Serum and pleural fluid N-Terminal-Pro-B-Type natriuretic peptide concentrations in the differential diagnosis of pleural effusions.
Yorgancıoğlu A; Ozgen Alpaydın A; Yaman N; Taneli F; Bayturan O; Sakar Coşkun A; Celik P
Tuberk Toraks; 2011; 59(1):1-7. PubMed ID: 21554224
[TBL] [Abstract][Full Text] [Related]
9. [Contribution of pleural fluid analysis to the diagnosis of pleural effusion].
Ferreiro L; Toubes ME; Valdés L
Med Clin (Barc); 2015 Aug; 145(4):171-7. PubMed ID: 25433793
[TBL] [Abstract][Full Text] [Related]
10. Concordant and Discordant Exudates and Their Effect on the Accuracy of Light's Criteria to Diagnose Exudative Pleural Effusions.
Ferreiro L; Sánchez-Sánchez R; Valdés L; Kummerfeldt CE; Huggins JT
Am J Med Sci; 2016 Dec; 352(6):549-556. PubMed ID: 27916209
[TBL] [Abstract][Full Text] [Related]
11. Pleural effusions.
Light RW
Med Clin North Am; 2011 Nov; 95(6):1055-70. PubMed ID: 22032427
[TBL] [Abstract][Full Text] [Related]
12. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions.
Kolditz M; Halank M; Schiemanck CS; Schmeisser A; Höffken G
Eur Respir J; 2006 Jul; 28(1):144-50. PubMed ID: 16481382
[TBL] [Abstract][Full Text] [Related]
13. Pleural fluid amino-terminal brain natriuretic peptide in patients with pleural effusions.
Cincin A; Abul Y; Ozben B; Tanrikulu A; Topaloglu N; Ozgul G; Karakurt S; Oktay A
Respir Care; 2013 Feb; 58(2):313-9. PubMed ID: 22710710
[TBL] [Abstract][Full Text] [Related]
14. [Pleural fluid to serum cholinesterase ratio to discriminate between transudates and exudates: reevaluation in 177 patients].
García Pachón E; Padilla Navas I; Molina Siles M; López-Azorín F
Rev Clin Esp; 1998 Mar; 198(3):129-32. PubMed ID: 9586433
[TBL] [Abstract][Full Text] [Related]
15. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
16. Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts.
Yang Q; Niu Y; Wen JX; Yang DN; Han YL; Wen XH; Yan L; Huang JH; Chen H; Zheng WQ; Jiang TW; Hu ZD
Ther Adv Respir Dis; 2023; 17():17534666231216566. PubMed ID: 38084849
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of Light's criteria and other biochemical parameters for distinguishing transudates from exudates.
Gázquez I; Porcel JM; Vives M; Vicente de Vera MC; Rubio M; Rivas MC
Respir Med; 1998 May; 92(5):762-5. PubMed ID: 9713637
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions.
Lieser EA; Croghan GA; Nevala WK; Bradshaw MJ; Markovic SN; Mansfield AS
Lung Cancer; 2013 Oct; 82(1):63-8. PubMed ID: 23948549
[TBL] [Abstract][Full Text] [Related]
19. Untargeted mass spectrometry-based metabolomic profiling of pleural effusions: fatty acids as novel cancer biomarkers for malignant pleural effusions.
Lam CW; Law CY
J Proteome Res; 2014 Sep; 13(9):4040-6. PubMed ID: 25117182
[TBL] [Abstract][Full Text] [Related]
20. [Role of c-c chemokines in the determination of pleural effusion etiology].
Trzaska-Sobczak M; Pierzchała W; Brozek G; Farnik M
Wiad Lek; 2008; 61(7-9):190-4. PubMed ID: 19172830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
